Accounting for the cost of scaling-up health interventions

Health Economics
Benjamin Johns, R Baltussen

Abstract

Recent studies such as the Commission on Macroeconomics and Health have highlighted the need for expanding the coverage of services for HIV/AIDS, malaria, tuberculosis, immunisations and other diseases. In order for policy makers to plan for these changes, they need to analyse the change in costs when interventions are 'scaled-up' to cover greater percentages of the population. Previous studies suggest that applying current unit costs to an entire population can misconstrue the true costs of an intervention. This study presents the methodology used in WHO-CHOICE's generalised cost effectiveness analysis, which includes non-linear cost functions for health centres, transportation and supervision costs, as well as the presence of fixed costs of establishing a health infrastructure. Results show changing marginal costs as predicted by economic theory.

References

Jan 1, 1983·Social Science & Medicine·R Stock
Aug 1, 1994·Social Science & Medicine·L Brenzel, P Claquin
Mar 23, 2000·Social Science & Medicine·B Perry, W Gesler
Jun 1, 2000·Social Science & Medicine·J L FiedlerM V Magpantay

❮ Previous
Next ❯

Citations

Jan 15, 2010·Health Policy and Planning·Lindsay J Mangham, Kara Hanson
Aug 9, 2011·Health Policy and Planning·Ligia Paina, David H Peters
Nov 12, 2005·BMJ : British Medical Journal·Chantal M MorelDavid B Evans
Nov 12, 2005·BMJ : British Medical Journal·Rob BaltussenChristopher Dye
Apr 5, 2012·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Yoko IbukaAlison P Galvani
Jul 14, 2007·BMC Health Services Research·Elliot MarseilleJames G Kahn
Jun 10, 2009·Malaria Journal·Fabrizio TediosiThomas A Smith
Aug 23, 2006·Cost Effectiveness and Resource Allocation : C/E·Rob Baltussen, Louis Niessen
Mar 30, 2011·PLoS Medicine·Christa L Fischer WalkerRobert E Black
Mar 23, 2013·Journal of the International AIDS Society·Andrew D PintoSumeet K Sodhi
Apr 30, 2015·Best Practice & Research. Clinical Obstetrics & Gynaecology·Anne-Marie BerghRobert C Pattinson
Jul 25, 2015·Malaria Journal·Peter Pemberton-RossMelissa A Penny
Aug 13, 2015·Implementation Science : IS·Andrew J MilatSally Redman
Apr 3, 2012·American Journal of Obstetrics and Gynecology·Luz GibbonsFernando Althabe
Oct 14, 2017·Health Policy and Planning·Omar GalárragaJoseph K Wang'ombe
Nov 11, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Hugo C TurnerRoy M Anderson
Sep 16, 2020·Malaria Journal·Katya GalactionovaMelissa A Penny
Dec 11, 2019·Bulletin of the World Health Organization·Joseph Wong, Kimberly Skead
Oct 30, 2020·International Journal of Environmental Research and Public Health·Matteo RuggeriMarco Marchetti
Mar 12, 2021·Health Policy and Planning·Rabiah Al AdawiyahVirginia Wiseman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.